Perioperative analgesic approaches in hepatobiliary cancer malignancies: Experience from a tertiary care centre. Camrelizumab plus rivoceranib as first-line maintenance therapy after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results